Skip to main content
Britannia Life Sciences logo

Britannia Life Sciences — Investor Relations & Filings

Ticker · BLAB ISIN · CA11042D1087 LEI · 549300PN0TMPKNE2R614 CSE Professional, scientific and technical activities
Filings indexed 128 across all filing types
Latest filing 2020-04-07 Regulatory Filings
Country CA Canada
Listing CSE BLAB

About Britannia Life Sciences

https://britannia.life/

Britannia Life Sciences operates as a global, vertically diversified product development platform, offering an integrated suite of services that function as a "one-stop-shop" across the entire product lifecycle, from concept to consumer. The company specializes in quality assurance, safety assessment, regulatory compliance, and comprehensive product testing. Core services are delivered through an ISO 17025 accredited laboratory, supporting businesses in the cosmetics, consumer packaged and household goods, nutraceutical, food, and general wellness sectors. The platform includes specialized divisions such as Britannia Labs, which serves the global cannabis industry, and Proof Wellness, an online marketplace for CBD consumers. The company focuses on leveraging its expertise to support clients primarily targeting the UK and European markets.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Regulatory Filings
2020-04-07 English
Audited annual financial statements – English.pdf
Regulatory Filings
2020-04-07 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2020-04-07 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2020-04-07 English
Notice.pdf
Regulatory Filings
2020-02-14 English
Letter from former auditor.pdf
Regulatory Filings
2020-02-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.